Statistics

Total Visits

Views
Cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: analysis by age group12

Select a period of time:

Number of views in the range

Views
Cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: analysis by age group10

Views

Views
November 20230
December 20230
January 20247
February 20240
March 20240
April 20240
May 20243
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
Italy1
 

Top cities views

Views
Boardman6
Arezzo1
Chicago1